Characteristics of Cardiac Ketone Body Metabolism Throughout the Life Cycle

IF 3.4 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Lei Li, Xiaojian Song, Xiurui Ma, Yanwu Xu
{"title":"Characteristics of Cardiac Ketone Body Metabolism Throughout the Life Cycle","authors":"Lei Li,&nbsp;Xiaojian Song,&nbsp;Xiurui Ma,&nbsp;Yanwu Xu","doi":"10.1155/cdr/5913327","DOIUrl":null,"url":null,"abstract":"<p>Ketone bodies can serve as energy substrates for the heart and perform important molecular signal transduction functions. In recent years, the therapeutic potential of ketone bodies has become a research hotspot in the field of cardiovascular diseases. Many previous reviews have focused on ketone bodies from the perspective of cardiovascular diseases, especially heart failure. Nonetheless, the metabolism of cardiac ketone bodies under physiological conditions also warrants attention, as the consumption of a ketogenic diet or direct supplementation of ketone bodies from exogenous sources has become widely popular among healthy individuals for weight loss. Furthermore, recent clinical studies have shown that under physiological conditions, the level of ketone bodies is positively correlated with the incidence of cardiovascular diseases and mortality. On the basis of the differences in cardiac ketone body metabolism under healthy and disease conditions, in this review, we describe in detail the characteristics of cardiac ketone body metabolism and the significance of elevated circulating ketone body levels throughout the life cycle on physiological states.</p>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2025 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/cdr/5913327","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/cdr/5913327","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Ketone bodies can serve as energy substrates for the heart and perform important molecular signal transduction functions. In recent years, the therapeutic potential of ketone bodies has become a research hotspot in the field of cardiovascular diseases. Many previous reviews have focused on ketone bodies from the perspective of cardiovascular diseases, especially heart failure. Nonetheless, the metabolism of cardiac ketone bodies under physiological conditions also warrants attention, as the consumption of a ketogenic diet or direct supplementation of ketone bodies from exogenous sources has become widely popular among healthy individuals for weight loss. Furthermore, recent clinical studies have shown that under physiological conditions, the level of ketone bodies is positively correlated with the incidence of cardiovascular diseases and mortality. On the basis of the differences in cardiac ketone body metabolism under healthy and disease conditions, in this review, we describe in detail the characteristics of cardiac ketone body metabolism and the significance of elevated circulating ketone body levels throughout the life cycle on physiological states.

心脏酮体全生命周期代谢特征
酮体可以作为心脏的能量底物,并执行重要的分子信号转导功能。近年来,酮体的治疗潜力已成为心血管疾病领域的研究热点。许多文献从心血管疾病特别是心力衰竭的角度对酮体进行了研究。尽管如此,心脏酮体在生理条件下的代谢也值得关注,因为食用生酮饮食或从外源直接补充酮体已在健康人群中广泛流行,以减轻体重。此外,最近的临床研究表明,在生理条件下,酮体水平与心血管疾病的发病率和死亡率呈正相关。基于健康和疾病状态下心脏酮体代谢的差异,本文详细阐述了心脏酮体代谢的特点以及整个生命周期循环酮体水平升高对生理状态的意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular Therapeutics
Cardiovascular Therapeutics 医学-心血管系统
CiteScore
5.60
自引率
0.00%
发文量
55
审稿时长
6 months
期刊介绍: Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): Acute coronary syndrome Arrhythmias Atherosclerosis Basic cardiac electrophysiology Cardiac catheterization Cardiac remodeling Coagulation and thrombosis Diabetic cardiovascular disease Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) Hyperlipidemia Hypertension Ischemic heart disease Vascular biology Ventricular assist devices Molecular cardio-biology Myocardial regeneration Lipoprotein metabolism Radial artery access Percutaneous coronary intervention Transcatheter aortic and mitral valve replacement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信